{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:16:17Z","timestamp":1776057377212,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02646-x","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T05:01:54Z","timestamp":1685509314000},"page":"2491-2503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A review of heart transplant immunosuppressants and nonmelanoma skin cancer"],"prefix":"10.1007","volume":"315","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3981-5763","authenticated-orcid":false,"given":"Daphne G.","family":"Eckembrecher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-6785","authenticated-orcid":false,"given":"Francelia J.","family":"Eckembrecher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4964-9137","authenticated-orcid":false,"given":"Isabella","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8407-9339","authenticated-orcid":false,"given":"Hemali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5749-6180","authenticated-orcid":false,"given":"Yogi","family":"Dave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrey","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyvan","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"issue":"3","key":"2646_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.soncn.2013.06.002","volume":"29","author":"R Gordon","year":"2013","unstructured":"Gordon R (2013) Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs 29(3):160\u2013169. https:\/\/doi.org\/10.1016\/j.soncn.2013.06.002","journal-title":"Semin Oncol Nurs"},{"issue":"1","key":"2646_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fsc.2018.08.001","volume":"27","author":"MG Brandt","year":"2019","unstructured":"Brandt MG, Moore CC (2019) Nonmelanoma skin cancer. Facial Plast Surg Clin North Am 27(1):1\u201313. https:\/\/doi.org\/10.1016\/j.fsc.2018.08.001","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"1","key":"2646_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0974-2077.94323","volume":"5","author":"V Samarasinghe","year":"2012","unstructured":"Samarasinghe V, Madan V (2012) Nonmelanoma skin cancer. J Cutan Aesthet Surg 5(1):3\u201310. https:\/\/doi.org\/10.4103\/0974-2077.94323","journal-title":"J Cutan Aesthet Surg"},{"issue":"1","key":"2646_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.det.2018.07.009","volume":"37","author":"L Collins","year":"2019","unstructured":"Collins L, Quinn A, Stasko T (2019) Skin cancer and immunosuppression. Dermatol Clin 37(1):83\u201394. https:\/\/doi.org\/10.1016\/j.det.2018.07.009","journal-title":"Dermatol Clin"},{"issue":"Suppl 3","key":"2646_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1365-2133.2009.09453.x","volume":"161","author":"C Ulrich","year":"2009","unstructured":"Ulrich C, J\u00fcrgensen JS, Degen A et al (2009) Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 161(Suppl 3):78\u201384. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09453.x","journal-title":"Br J Dermatol"},{"key":"2646_CR6","doi-asserted-by":"publisher","unstructured":"Mancini D, Rakita V (2018) Malignancy Post Heart Transplantation: No Free Lunch. J Am Coll Cardiol 71(1):50-52. https:\/\/doi.org\/10.1016\/j.jacc.2017.11.027","DOI":"10.1016\/j.jacc.2017.11.027"},{"issue":"8","key":"2646_CR7","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1016\/j.transproceed.2010.08.003","volume":"42","author":"BD Molina","year":"2010","unstructured":"Molina BD, Leiro MG, Pulp\u00f3n LA et al (2010) Incidence and risk factors for nonmelanoma skin cancer after heart transplantation. Transplant Proc 42(8):3001\u20133005. https:\/\/doi.org\/10.1016\/j.transproceed.2010.08.003","journal-title":"Transplant Proc"},{"issue":"4","key":"2646_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40257-018-0355-8","volume":"19","author":"MD Howard","year":"2018","unstructured":"Howard MD, Su JC, Chong AH (2018) Skin cancer following solid organ transplantation: a review of risk factors and models of care. Am J Clin Dermatol 19(4):585\u2013597. https:\/\/doi.org\/10.1007\/s40257-018-0355-8","journal-title":"Am J Clin Dermatol"},{"key":"2646_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ijscr.2021.01.031","volume":"79","author":"AS Ruwanpathirana","year":"2021","unstructured":"Ruwanpathirana AS, Fernando SJ, Vinati Molligoda M et al (2021) Recurrent squamous cell carcinoma in a post cardiac transplant patient. Int J Surg Case Rep 79:275\u2013280. https:\/\/doi.org\/10.1016\/j.ijscr.2021.01.031","journal-title":"Int J Surg Case Rep"},{"issue":"17","key":"2646_CR10","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1001\/jama.2011.1592","volume":"306","author":"EA Engels","year":"2011","unstructured":"Engels EA, Pfeiffer RM, Fraumeni JF et al (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306(17):1891\u20131901. https:\/\/doi.org\/10.1001\/jama.2011.1592","journal-title":"JAMA"},{"issue":"12","key":"2646_CR11","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1001\/archdermatol.2009.276","volume":"145","author":"JD Brewer","year":"2009","unstructured":"Brewer JD, Colegio OR, Phillips PK et al (2009) Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol 145(12):1391\u20131396. https:\/\/doi.org\/10.1001\/archdermatol.2009.276","journal-title":"Arch Dermatol"},{"issue":"2 Pt 1","key":"2646_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/0190-9622(95)90239-2","volume":"33","author":"S Euvrard","year":"1995","unstructured":"Euvrard S, Kanitakis J, Pouteil-Noble C et al (1995) Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 33(2 Pt 1):222\u2013229. https:\/\/doi.org\/10.1016\/0190-9622(95)90239-2","journal-title":"J Am Acad Dermatol"},{"key":"2646_CR13","volume-title":"Cyclosporine","author":"C Tapia","year":"2022","unstructured":"Tapia C, Nessel TA, Zito PM (2022) Cyclosporine. StatPearls"},{"issue":"4","key":"2646_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.intimp.2013.02.012","volume":"15","author":"M Faulhaber","year":"2013","unstructured":"Faulhaber M, M\u00e4ding I, Malehsa D et al (2013) Steroid withdrawal and reduction of cyclosporine A under mycophenolate mofetil after heart transplantation. Int Immunopharmacol 15(4):712\u2013717. https:\/\/doi.org\/10.1016\/j.intimp.2013.02.012","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"2646_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3109\/09546634.2011.590792","volume":"23","author":"MW Muellenhoff","year":"2012","unstructured":"Muellenhoff MW, Koo JY (2012) Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology. J Dermatolog Treat 23(4):290\u2013304. https:\/\/doi.org\/10.3109\/09546634.2011.590792","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"2646_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s13555-020-00409-4","volume":"10","author":"DMW Balak","year":"2020","unstructured":"Balak DMW, Gerdes S, Parodi A et al (2020) Long-term safety of oral systemic therapies for psoriasis: a comprehensive review of the literature. Dermatol Ther (Heidelb) 10(4):589\u2013613. https:\/\/doi.org\/10.1007\/s13555-020-00409-4","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"3","key":"2646_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.bbrc.2011.02.039","volume":"408","author":"J Xu","year":"2011","unstructured":"Xu J, Walsh SB, Verney ZM et al (2011) Procarcinogenic effects of cyclosporine A are mediated through the activation of TAK1\/TAB1 signaling pathway. Biochem Biophys Res Commun 408(3):363\u2013368. https:\/\/doi.org\/10.1016\/j.bbrc.2011.02.039","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2646_CR18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/mc.20744","volume":"50","author":"SB Walsh","year":"2011","unstructured":"Walsh SB, Xu J, Xu H et al (2011) Cyclosporine a mediates pathogenesis of aggressive cutaneous squamous cell carcinoma by augmenting epithelial-mesenchymal transition: role of TGF\u03b2 signaling pathway. Mol Carcinog 50(7):516\u2013527. https:\/\/doi.org\/10.1002\/mc.20744","journal-title":"Mol Carcinog"},{"issue":"17","key":"2646_CR19","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2165\/00003495-200666170-00010","volume":"66","author":"PL McCormack","year":"2006","unstructured":"McCormack PL, Keating GM (2006) Tacrolimus: in heart transplant recipients. Drugs 66(17):2269\u20132279. https:\/\/doi.org\/10.2165\/00003495-200666170-00010. (discussion 2280-2)","journal-title":"Drugs"},{"issue":"5","key":"2646_CR20","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/j.1600-6143.2008.02196.x","volume":"8","author":"MG Crespo-Leiro","year":"2008","unstructured":"Crespo-Leiro MG, Alonso-Pulp\u00f3n L, de V\u00e1zquez Prada JA et al (2008) Malignancy after heart transplantation: incidence, prognosis and risk factors. Am J Transplant 8(5):1031\u20131039. https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02196.x","journal-title":"Am J Transplant"},{"issue":"9","key":"2646_CR21","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1016\/j.transproceed.2010.07.090","volume":"42","author":"J Signorell","year":"2010","unstructured":"Signorell J, Hunziker T, Martinelli M et al (2010) Recurrent non-melanoma skin cancer: remission of field cancerization after conversion from calcineurin inhibitor- to proliferation signal inhibitor-based immunosuppression in a cardiac transplant recipient. Transplant Proc 42(9):3871\u20133875. https:\/\/doi.org\/10.1016\/j.transproceed.2010.07.090","journal-title":"Transplant Proc"},{"issue":"1","key":"2646_CR22","doi-asserted-by":"publisher","first-page":"100655","DOI":"10.1016\/j.trre.2021.100655","volume":"36","author":"H Tedesco-Silva","year":"2022","unstructured":"Tedesco-Silva H, Saliba F, Barten MJ et al (2022) An overview of the efficacy and safety of everolimus in adult solid organ transplant recipients. Transplant Rev (Orlando) 36(1):100655. https:\/\/doi.org\/10.1016\/j.trre.2021.100655","journal-title":"Transplant Rev (Orlando)"},{"issue":"8","key":"2646_CR23","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1432-2277.2009.01010.x","volume":"23","author":"S Euvrard","year":"2010","unstructured":"Euvrard S, Boissonnat P, Roussouli\u00e8res A et al (2010) Effect of everolimus on skin cancers in calcineurin inhihitor-treated heart transplant recipients. Transpl Int 23(8):855\u2013857. https:\/\/doi.org\/10.1111\/j.1432-2277.2009.01010.x","journal-title":"Transpl Int"},{"issue":"5","key":"2646_CR24","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.transproceed.2011.01.174","volume":"43","author":"B Baur","year":"2011","unstructured":"Baur B, Oroszlan M, Hess O et al (2011) Efficacy and safety of sirolimus and everolimus in heart transplant patients: a retrospective analysis. Transplant Proc 43(5):1853\u20131861. https:\/\/doi.org\/10.1016\/j.transproceed.2011.01.174","journal-title":"Transplant Proc"},{"issue":"9","key":"2646_CR25","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/cam4.487","volume":"4","author":"EL Yanik","year":"2015","unstructured":"Yanik EL, Siddiqui K, Engels EA (2015) Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis. Cancer Med 4(9):1448\u20131459. https:\/\/doi.org\/10.1002\/cam4.487","journal-title":"Cancer Med"},{"issue":"6","key":"2646_CR26","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jaad.2015.12.044","volume":"74","author":"R Na","year":"2016","unstructured":"Na R, Laaksonen MA, Grulich AE et al (2016) High azathioprine dose and lip cancer risk in liver, heart, and lung transplant recipients: a population-based cohort study. J Am Acad Dermatol 74(6):1144-1152.e6. https:\/\/doi.org\/10.1016\/j.jaad.2015.12.044","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2646_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMoa1204166","volume":"367","author":"S Euvrard","year":"2012","unstructured":"Euvrard S, Morelon E, Rostaing L et al (2012) Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med 367(4):329\u2013339. https:\/\/doi.org\/10.1056\/NEJMoa1204166","journal-title":"N Engl J Med"},{"issue":"21","key":"2646_CR28","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1016\/j.jacc.2019.03.499","volume":"73","author":"R Asleh","year":"2019","unstructured":"Asleh R, Clavell AL, Pereira NL et al (2019) Incidence of malignancies in patients treated with sirolimus following heart transplantation. J Am Coll Cardiol 73(21):2676\u20132688. https:\/\/doi.org\/10.1016\/j.jacc.2019.03.499","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2646_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa326","volume":"4","author":"J Feinman","year":"2020","unstructured":"Feinman J, Rollins B, Contreras J et al (2020) Pancytopenia caused by allopurinol and azathioprine interaction in a heart transplant patient: a case report. Eur Heart J Case Rep 4(6):1\u20134. https:\/\/doi.org\/10.1093\/ehjcr\/ytaa326","journal-title":"Eur Heart J Case Rep"},{"issue":"8","key":"2646_CR30","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1172\/JCI18384","volume":"111","author":"JS Maltzman","year":"2003","unstructured":"Maltzman JS, Koretzky GA (2003) Azathioprine: old drug, new actions. J Clin Invest 111(8):1122\u20131124. https:\/\/doi.org\/10.1172\/JCI18384","journal-title":"J Clin Invest"},{"issue":"12","key":"2646_CR31","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1111\/ajt.13863","volume":"16","author":"Z Jiyad","year":"2016","unstructured":"Jiyad Z, Olsen CM, Burke MT et al (2016) Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis. Am J Transplant 16(12):3490\u20133503. https:\/\/doi.org\/10.1111\/ajt.13863","journal-title":"Am J Transplant"},{"issue":"5","key":"2646_CR32","first-page":"277","volume":"15","author":"MG Peters","year":"2019","unstructured":"Peters MG (2019) Long-term use of azathioprine in the management of autoimmune hepatitis. Gastroenterol Hepatol (N Y) 15(5):277\u2013279","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"1","key":"2646_CR33","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.athoracsur.2003.07.006","volume":"77","author":"XM Mueller","year":"2004","unstructured":"Mueller XM (2004) Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants. Ann Thorac Surg 77(1):354\u2013362. https:\/\/doi.org\/10.1016\/j.athoracsur.2003.07.006","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"2646_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/ajt.13596","volume":"16","author":"AE Coghill","year":"2016","unstructured":"Coghill AE, Johnson LG, Berg D et al (2016) Immunosuppressive medications and squamous cell skin carcinoma: nested case-control study within the skin cancer after organ transplant (SCOT) cohort. Am J Transplant 16(2):565\u2013573. https:\/\/doi.org\/10.1111\/ajt.13596","journal-title":"Am J Transplant"},{"issue":"10","key":"2646_CR35","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.healun.2006.06.010","volume":"25","author":"JO O'Neill","year":"2006","unstructured":"O\u2019Neill JO, Edwards LB, Taylor DO (2006) Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 25(10):1186\u20131191. https:\/\/doi.org\/10.1016\/j.healun.2006.06.010","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"2646_CR36","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.bjps.2017.03.005","volume":"70","author":"L Kearney","year":"2017","unstructured":"Kearney L, Hogan D, Conlon P et al (2017) High-risk cutaneous malignancies and immunosuppression: challenges for the reconstructive surgeon in the renal transplant population. J Plast Reconstr Aesthet Surg 70(7):922\u2013930. https:\/\/doi.org\/10.1016\/j.bjps.2017.03.005","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"2","key":"2646_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7182\/pit2015826","volume":"25","author":"K Billups","year":"2015","unstructured":"Billups K, Neal J, Salyer J (2015) Immunosuppressant-driven de novo malignant neoplasms after solid-organ transplant. Prog Transplant 25(2):182\u2013188. https:\/\/doi.org\/10.7182\/pit2015826","journal-title":"Prog Transplant"},{"issue":"8","key":"2646_CR38","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1093\/ndt\/gfp425","volume":"25","author":"A Ingvar","year":"2010","unstructured":"Ingvar A, Smedby KE, Lindel\u00f6f B et al (2010) Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma. Nephrol Dial Transplant 25(8):2764\u20132771. https:\/\/doi.org\/10.1093\/ndt\/gfp425","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2646_CR39","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/ijc.27765","volume":"132","author":"B Krynitz","year":"2013","unstructured":"Krynitz B, Edgren G, Lindel\u00f6f B et al (2013) Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008\u2013a Swedish population-based study. Int J Cancer 132(6):1429\u20131438. https:\/\/doi.org\/10.1002\/ijc.27765","journal-title":"Int J Cancer"},{"issue":"1","key":"2646_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0190-9622(99)70525-6","volume":"40","author":"CS Ong","year":"1999","unstructured":"Ong CS, Keogh AM, Kossard S et al (1999) Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 40(1):27\u201334. https:\/\/doi.org\/10.1016\/s0190-9622(99)70525-6","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2646_CR41","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1365-2133.2011.10591.x","volume":"166","author":"L Feldmeyer","year":"2012","unstructured":"Feldmeyer L, Hofbauer GF, B\u00f6ni T et al (2012) Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing. Br J Dermatol 166(2):422\u2013424. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10591.x","journal-title":"Br J Dermatol"},{"issue":"2","key":"2646_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1524-4725.2005.31038","volume":"31","author":"CC Otley","year":"2005","unstructured":"Otley CC, Maragh SL (2005) Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy. Dermatol Surg 31(2):163\u2013168. https:\/\/doi.org\/10.1111\/j.1524-4725.2005.31038","journal-title":"Dermatol Surg"},{"issue":"4","key":"2646_CR43","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jaad.2012.09.030","volume":"68","author":"R Gogia","year":"2013","unstructured":"Gogia R, Binstock M, Hirose R et al (2013) Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation. J Am Acad Dermatol 68(4):585\u2013591. https:\/\/doi.org\/10.1016\/j.jaad.2012.09.030","journal-title":"J Am Acad Dermatol"},{"issue":"2\u20133","key":"2646_CR44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1600-0781.2007.00282.x","volume":"23","author":"ME Laing","year":"2007","unstructured":"Laing ME, Kay E, Conlon P et al (2007) Genetic factors associated with skin cancer in renal transplant patients. Photodermatol Photoimmunol Photomed 23(2\u20133):62\u201367. https:\/\/doi.org\/10.1111\/j.1600-0781.2007.00282.x","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"3","key":"2646_CR45","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","volume":"153","author":"GL Garrett","year":"2017","unstructured":"Garrett GL, Blanc PD, Boscardin J et al (2017) Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatol 153(3):296\u2013303. https:\/\/doi.org\/10.1001\/jamadermatol.2016.4920","journal-title":"JAMA Dermatol"},{"issue":"6","key":"2646_CR46","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/TP.0000000000001286","volume":"101","author":"W Kang","year":"2017","unstructured":"Kang W, Sampaio MS, Huang E et al (2017) Association of pretransplant skin cancer with posttransplant malignancy, graft failure and death in kidney transplant recipients. Transplantation 101(6):1303\u20131309. https:\/\/doi.org\/10.1097\/TP.0000000000001286","journal-title":"Transplantation"},{"issue":"12","key":"2646_CR47","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1001\/archderm.136.12.1524","volume":"136","author":"I Marcil","year":"2000","unstructured":"Marcil I, Stern RS (2000) Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 136(12):1524\u20131530. https:\/\/doi.org\/10.1001\/archderm.136.12.1524","journal-title":"Arch Dermatol"},{"issue":"3","key":"2646_CR48","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/ajt.16210","volume":"21","author":"J Kentley","year":"2021","unstructured":"Kentley J, Allawh R, Rao S et al (2021) The burden of cutaneous disease in solid organ transplant recipients of color. Am J Transplant 21(3):1215\u20131226. https:\/\/doi.org\/10.1111\/ajt.16210","journal-title":"Am J Transplant"},{"issue":"6","key":"2646_CR49","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/jamadermatol.2017.0045","volume":"153","author":"CL Chung","year":"2017","unstructured":"Chung CL, Nadhan KS, Shaver CM et al (2017) Comparison of posttransplant dermatologic diseases by race. JAMA Dermatol 153(6):552\u2013558. https:\/\/doi.org\/10.1001\/jamadermatol.2017.0045","journal-title":"JAMA Dermatol"},{"issue":"12","key":"2646_CR50","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1001\/jamadermatol.2016.3328","volume":"152","author":"EN Pritchett","year":"2016","unstructured":"Pritchett EN, Doyle A, Shaver CM et al (2016) Nonmelanoma skin cancer in nonwhite organ transplant recipients. JAMA Dermatol 152(12):1348\u20131353. https:\/\/doi.org\/10.1001\/jamadermatol.2016.3328","journal-title":"JAMA Dermatol"},{"key":"2646_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-022-02371-x","author":"J Wang","year":"2022","unstructured":"Wang J, Lopez S, Trevi\u00f1o AM et al (2022) Evaluating awareness of skin cancer in skin of color organ transplant recipients. Arch Dermatol Res. https:\/\/doi.org\/10.1007\/s00403-022-02371-x","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"2646_CR52","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/tri.13520","volume":"32","author":"LD Crow","year":"2019","unstructured":"Crow LD, Jambusaria-Pahlajani A, Chung CL et al (2019) Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines. Transpl Int 32(12):1268\u20131276. https:\/\/doi.org\/10.1111\/tri.13520","journal-title":"Transpl Int"},{"issue":"6","key":"2646_CR53","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.transproceed.2017.03.079","volume":"49","author":"PH Patel","year":"2017","unstructured":"Patel PH, Bibee K, Lim G et al (2017) Evaluating retention of skin cancer education in kidney transplant recipients reveals a window of opportunity for re-education. Transplant Proc 49(6):1318\u20131324. https:\/\/doi.org\/10.1016\/j.transproceed.2017.03.079","journal-title":"Transplant Proc"},{"issue":"6","key":"2646_CR54","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1001\/archderm.142.6.712","volume":"142","author":"HE Clowers-Webb","year":"2006","unstructured":"Clowers-Webb HE, Christenson LJ, Phillips PK et al (2006) Educational outcomes regarding skin cancer in organ transplant recipients: randomized intervention of intensive vs standard education. Arch Dermatol 142(6):712\u2013718. https:\/\/doi.org\/10.1001\/archderm.142.6.712","journal-title":"Arch Dermatol"},{"issue":"17","key":"2646_CR55","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","volume":"373","author":"AC Chen","year":"2015","unstructured":"Chen AC, Martin AJ, Choy B et al (2015) A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med 373(17):1618\u20131626. https:\/\/doi.org\/10.1056\/NEJMoa1506197","journal-title":"N Engl J Med"},{"issue":"3","key":"2646_CR56","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/0190-9622(95)90069-1","volume":"32","author":"A Espa\u00f1a","year":"1995","unstructured":"Espa\u00f1a A, Redondo P, Fern\u00e1ndez AL et al (1995) Skin cancer in heart transplant recipients. J Am Acad Dermatol 32(3):458\u2013465. https:\/\/doi.org\/10.1016\/0190-9622(95)90069-1","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2646_CR57","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2340\/0001555575400403","volume":"75","author":"P Jensen","year":"1995","unstructured":"Jensen P, Clausen OP, Geiran O et al (1995) Cutaneous complications in heart transplant recipients in Norway 1983\u20131993. Acta Derm Venereol 75(5):400\u2013403. https:\/\/doi.org\/10.2340\/0001555575400403","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"2646_CR58","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1399-0012.1996.tb00437.x","volume":"10","author":"ML Mihalov","year":"1996","unstructured":"Mihalov ML, Gattuso P, Abraham K et al (1996) Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 10(3):248\u2013255","journal-title":"Clin Transplant"},{"issue":"Suppl 1","key":"2646_CR59","doi-asserted-by":"publisher","first-page":"S380","DOI":"10.1007\/s001470050366","volume":"13","author":"P Gjersvik","year":"2000","unstructured":"Gjersvik P, Hansen S, M\u00f8ller B et al (2000) Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients? Transpl Int 13(Suppl 1):S380\u2013S381. https:\/\/doi.org\/10.1007\/s001470050366","journal-title":"Transpl Int"},{"issue":"9","key":"2646_CR60","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1365-4632.2008.03711.x","volume":"47","author":"A Geusau","year":"2008","unstructured":"Geusau A, Dunkler D, Messeritsch E et al (2008) Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy. Int J Dermatol 47(9):918\u2013925. https:\/\/doi.org\/10.1111\/j.1365-4632.2008.03711.x","journal-title":"Int J Dermatol"},{"issue":"5","key":"2646_CR61","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1540-8191.2009.00858.x","volume":"24","author":"T Yagdi","year":"2009","unstructured":"Yagdi T, Sharples L, Tsui S et al (2009) Malignancy after heart transplantation: analysis of 24-year experience at a single center. J Card Surg 24(5):572\u2013579. https:\/\/doi.org\/10.1111\/j.1540-8191.2009.00858.x","journal-title":"J Card Surg"},{"issue":"3","key":"2646_CR62","first-page":"411","volume":"6","author":"T Strecker","year":"2013","unstructured":"Strecker T, R\u00f6sch J, Weyand M et al (2013) Frequency and spectrum of metachronous malignancies in heart transplant recipients: a 11-year-experience at a German heart center. Int J Clin Exp Pathol 6(3):411\u2013420","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"2646_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0036933017736423","volume":"63","author":"I McPherson","year":"2018","unstructured":"McPherson I, Kirk A (2018) The incidence of non-melanoma skin cancer and post-transplant lympho-proliferative disorders in the Scottish cardiac transplant population and the provision of specialist dermatological follow-up. Scott Med J 63(1):3\u201310. https:\/\/doi.org\/10.1177\/0036933017736423","journal-title":"Scott Med J"},{"issue":"6","key":"2646_CR64","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1080\/0284186X.2019.1580385","volume":"58","author":"S J\u00e4\u00e4maa-Holmberg","year":"2019","unstructured":"J\u00e4\u00e4maa-Holmberg S, Salmela B, Lemstr\u00f6m K et al (2019) Cancer incidence and mortality after heart transplantation - a population-based national cohort study. Acta Oncol 58(6):859\u2013863. https:\/\/doi.org\/10.1080\/0284186X.2019.1580385","journal-title":"Acta Oncol"},{"issue":"2","key":"2646_CR65","doi-asserted-by":"publisher","first-page":"224","DOI":"10.6002\/ect.2019.0210","volume":"18","author":"CC Yeh","year":"2020","unstructured":"Yeh CC, Khan A, Muo CH et al (2020) De novo malignancy after heart, kidney, and liver transplant: a nationwide study in Taiwan. Exp Clin Transplant 18(2):224\u2013233. https:\/\/doi.org\/10.6002\/ect.2019.0210","journal-title":"Exp Clin Transplant"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02646-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02646-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02646-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T14:31:09Z","timestamp":1729521069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02646-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":65,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["2646"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02646-x","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"assertion":[{"value":"28 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DGE, FJE, IC, HS, YD, SP and KN declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}